Article

Wired.comWired.com on 2023-09-04 15:00

The Aftermath of a 'Miracle Cure' for a Rare Cancer

In 2001, Gleevec was approved as a treatment for chronic myelogenous leukemia. It was a revelation for personalized medicine—with harrowing financial ...

Related news